Liposomal Influenza Vaccine

ISSN： 1173-8804

Source： BioDrugs, Vol.11, Iss.2, 1999-02, pp. : 137-144

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liposomal Influenza Vaccine: A Viewpoint by John S. Oxford

By Oxford J.S.

BioDrugs, Vol. 11, Iss. 2, 1999-02 ,pp. : 145-146

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine

By Dooley M. Goa K.L.

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 61-69

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine: A Viewpoint by R. Baltussen

By Baltussen R.

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 70-71

Adis International

Access to resources Recommend Favorite

Efficacy of influenza vaccine in the elderly: reduction in risks of mortality and morbidity during an influenza A (H3N2) epidemic for the elderly in nursing homes

By Deguchi Y.

International Journal of Clinical & Laboratory Research, Vol. 30, Iss. 1, 2000-03 ,pp. : 1-4

Springer Publishing Company

Access to resources Recommend Favorite

Intanza® 15 μg Intradermal Seasonal Influenza Vaccine in Older Adults (Aged ≥60 Years)†: Profile Report

By Duggan Sean T. Plosker Greg L.

BioDrugs, Vol. 24, Iss. 6, 2010-12 ,pp. : 407-409

Adis International

Access to resources Recommend Favorite